New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AVEO;ODP;RAD;AMAT;NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 24, 2014
11:04 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
09:34 EDTRAD, AMATActive equity options trading on open
Subscribe for More Information
September 23, 2014
09:37 EDTAMATActive equity options trading on open
Subscribe for More Information
07:31 EDTNAVBNavidea awarded $1.67M fast track NIH SBIR grant for evaluation of Lymphoseek
Navidea Biopharmaceuticals announced the receipt of an initial notice of award for a Fast Track Small Business Innovation Research grant providing for up to $1.67M from the National Cancer Institute, National Institutes of Health, to fund evaluation of Lymphoseek Injection in women with cervical cancer. The multicenter, clinical study in patients with early cervical cancer will seek to assess and provide data in support of the use of Lymphoseek in sentinel lymph node biopsy procedures which identify and evaluate the lymph nodes most likely to harbor additional cancer. The SBIR grant is awarded in two parts with the potential for total grant money up to a total of $1.67M over two and a half years. The first six-month funding segment of $165,917, which has already been awarded, is expected to enable Navidea to identify and qualify trial sites and secure necessary contracts and Institutional Review Board approvals. The second funding segment could provide for up to an additional $1.5M to be used to accrue participants; perform the sentinel lymph node procedures and pathology evaluations; and perform data analyses to confirm the safety and effectiveness of Lymphoseek. This study is designed as a multicenter, open-label, within-patient comparative study of Lymphoseek and an alternative lymphatic mapping agent referred to as vital blue dye for detection of lymph nodes in patients with cervical cancer. The study, using lymphatic mapping and SLN biopsy procedures, will compare the abilities of Lymphoseek and the alternative agent to identify SLNs during cervical cancer surgery. Additionally, the sentinel node pathology will be contrasted between agents and between the pathology of other nodes that may be removed during the procedure. The study is expected to involve 40 patients and last 1.5 years.
September 22, 2014
08:04 EDTAMATApplied Materials merger uncertainty could be opportunity, says Pacific Crest
Pacific Crest believes that the merger between Applied Materials and Tokyo Electron could be delayed until next year, while there is a small chance of China denying the merger. However, the firm recommends buying Applied Materials on any weakness relating to merger uncertainty, as it thinks the stock is worth $25 on a standalone basis. It keeps an Outperform rating on the shares.
September 19, 2014
16:24 EDTRADStocks rise after Fed keeps pledge for 'considerable time' before rate hike
Subscribe for More Information
September 18, 2014
18:25 EDTNAVBOn The Fly: After Hours Movers
HIGHER: Concur (CNQR), up 19.5% after SAP (SAP) announced that it will acquire the company for $129 per share... Navidea Biopharmaceuticals (NAVB), up 9.8% after confirming FDA orphan designation for Lymphoseek... Molycorp (MCP), up 6.1% after Oaktree Capital reported a 9.1% passive stake in the company... JetBlue (JBLU), up 4.6% following CEO transition announcement... Wendy's (WEN), up 2.15% after Trian reported a 24.39% stake in the company... Sears Holdings (SHLD), up 2.6% after Fairholme Capital reported a 24% stake in the company... AMD (AMD), up 1% after announcing that it expanded an IP partnership with Synopsys (SNPS). DOWN AFTER EARNINGS: Red Hat (RHT), down 3%... Oracle (ORCL), down 2.4% following first quarter earnings miss and CEO transition... Tibco Software (TIBX), down 5.5%. ALSO LOWER: Quest Resource (QRHC), down 13.4% after filing an automatic common stock and warrant shelf... Eagle Rock (EROC), down 4.5% after filing to sell 53.34M common units for limited partners... Chatham Lodging (CLDT), down 3.3% after filing to sell 5M shares of common stock... Glu Mobile (GLUU), down 2.3% after filing to sell 9.98M shares of common stock for holders... Blackstone Mortgage (BXMT), down 1.6% after filing to sell 8M shares of common stock.
16:10 EDTNAVBNavidea confirms FDA orphan designation for Lymphoseek in head, neck cancers
Subscribe for More Information
16:00 EDTRADOptions Update; September 18, 2014
Subscribe for More Information
12:45 EDTRADOn The Fly: Midday Wrap
Subscribe for More Information
11:55 EDTRADRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
11:07 EDTNAVBNavidea granted orphan status for tilmanocept injection
Subscribe for More Information
10:27 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
09:36 EDTRADActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
09:15 EDTRADRite Aid remains 'optimistic' about FY16
Subscribe for More Information
09:02 EDTRADRite Aid sees current competitive enviornment to remain promotional in FY15
Subscribe for More Information
08:59 EDTRADOn The Fly: Pre-market Movers
Subscribe for More Information
07:04 EDTRADRite Aid cuts FY15 EPS view to 22c-33c, consensus 34c
Based upon current estimates for reimbursement rates and anticipated lower profitability from new generics and generic drugs that recently lost exclusivity, the company is expecting decreases in pharmacy margin in the second half of Fiscal 2015 as compared to its prior estimates and therefore is lowering its guidance for Adjusted EBITDA, net income and net income per diluted share. Previous EPS view was 30c-40c. Cuts FY15 high end of revenue view to $26B-$26.3B from $26B-$26.5B, consensus $26.29B. Now sees FY SSS up 3%-4% over FY14. Sees FY CapEx $525M. Sees adjusted EBITDA $1.2B-$1.275B.
07:02 EDTRADRite Aid reports Q2 EPS 13c, consensus 6c
Subscribe for More Information
September 17, 2014
15:18 EDTRADNotable companies reporting before tomorrow's open
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use